Document is current
Any future updates will be listed below
-
Authors
Xiang, Yi-Kui https://orcid.org/0000-0003-3432-6837
Türk, Murat https://orcid.org/0000-0002-3290-2661
Ojeda, Ivan Cherrez https://orcid.org/0000-0002-1610-239X
Elieh-Ali-Komi, Daniel https://orcid.org/0000-0003-0546-5280
Salman, Andac https://orcid.org/0000-0002-6407-926X
Kocatürk, Emek https://orcid.org/0000-0003-2801-0959
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Accepted: 11 September 2024
First Online: 20 September 2024
Declarations
:
: MT has no relevant conflict of interest in relation to this work. Outside of it, MT is or recently was a speaker and/or advisor for Novartis, AstraZeneca, GSK, Vem İlaç, Polifarma. EK is or recently was a speaker and/or advisor for Novartis, Menarini, LaRoche Posey, Sanofi, Bayer, outside the submitted work. The rest of the authors declare no conflict of interest.
